NM_001303256.3(MORC2):c.754C>T (p.Arg252Trp)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z|Inborn genetic diseases|Charcot-Marie-Tooth disease|Distal spinal muscular atrophy|not provided|Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
β
β
ββ2026β Residue 252
NM_001303256.3(MORC2):c.394C>T (p.Arg132Cys)Pathogenic
not provided|Charcot-Marie-Tooth disease axonal type 2Z|MORC2-related developmental disorder|Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy|Neurodevelopmental disorder|MORC2-related disorder
β
β
ββ2026β Residue 132
NM_001303256.3(MORC2):c.1270A>G (p.Thr424Ala)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z|Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy|not provided
β
β
ββ2025β Residue 424
NM_001303256.3(MORC2):c.260C>T (p.Ser87Leu)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z|not provided|Charcot-Marie-Tooth disease|Global developmental delay|Inborn genetic diseases|Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
β
β
ββ2025β Residue 87
NM_001303256.3(MORC2):c.79G>A (p.Glu27Lys)Pathogenic
not provided|Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy|MORC2-related neurodevelopmental disorders|Charcot-Marie-Tooth disease axonal type 2Z|Neurodevelopmental disorder|Inborn genetic diseases|MORC2-related disorder
β
β
ββ2025β Residue 27
NM_001303256.3(MORC2):c.1181A>G (p.Tyr394Cys)Pathogenic
not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2Z|MORC2-related disorder
β
β
ββ2025β Residue 394
NM_001303256.3(MORC2):c.707A>G (p.Glu236Gly)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z|Charcot-Marie-Tooth disease
β
β
ββ2025β Residue 236
NM_001303256.3(MORC2):c.71C>T (p.Thr24Ile)Likely pathogenic
not provided|Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy|Charcot-Marie-Tooth disease axonal type 2Z
β
β
ββ2024β Residue 24
NM_001303256.3(MORC2):c.395G>A (p.Arg132His)Pathogenic
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy|not provided
β
β
ββ2024β Residue 132
NM_001303256.3(MORC2):c.798G>C (p.Arg266Ser)Pathogenic
not provided|Charcot-Marie-Tooth disease axonal type 2Z
β
β
ββ2021β Residue 266
NM_001303256.3(MORC2):c.1219T>C (p.Cys407Arg)Likely pathogenic
Charcot-Marie-Tooth disease axonal type 2Z
β
βββ2025β Residue 407
NM_001303256.3(MORC2):c.755G>T (p.Arg252Leu)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z
β
βββ2025β Residue 252
NM_001303256.3(MORC2):c.64A>C (p.Asn22His)Likely pathogenic
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
β
βββ2024β Residue 22
NM_001303256.3(MORC2):c.810C>G (p.Cys270Trp)Likely pathogenic
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
β
βββ2024β Residue 270
NM_001303256.3(MORC2):c.1271C>G (p.Thr424Arg)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z
β
βββ2023β Residue 424
NM_001303256.3(MORC2):c.1217C>T (p.Ala406Val)Likely pathogenic
Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease axonal type 2Z
β
βββ2023β Residue 406
NM_001303256.3(MORC2):c.259T>C (p.Ser87Pro)Pathogenic
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
β
βββ2023β Residue 87
NM_001303256.3(MORC2):c.395G>T (p.Arg132Leu)Pathogenic
Charcot-Marie-Tooth disease axonal type 2Z
β
βββ2023β Residue 132
NM_001303256.3(MORC2):c.798G>T (p.Arg266Ser)Likely pathogenic
Charcot-Marie-Tooth disease axonal type 2Z
β
βββ2023β Residue 266
NM_001303256.3(MORC2):c.317C>T (p.Ser106Leu)Likely pathogenic
Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
β
βββ2022β Residue 106